跳至主要内容
临床试验/ISRCTN10150672
ISRCTN10150672暂停未知

A neurorehabilitation therapy based on a brain machine interface (BMI) for the motor function restoration of the upper limb in chronic stroke patients: Intracranial Stroke MOtor REhabilitation

Instituto de Investigación Sanitaria Biodonostia (Spain)0 个研究点目标入组 6 人开始时间: 2015年5月7日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Assessment of physical and psychological function and impairment:
  • 1. Wolf-Motor test
  • 2. Goal Attainment Scale (GAS)
  • 3. Motor Activity Log
  • 4. KVIQ-20
  • 5. Modified Ashworth scales (spasticity)
  • 6. Beck Depression Inventory (BDI)
  • 7. Hamilton Depression Rating Scale (HDRS)
  • 8. Berlin Social Support Scale (BSSS)
  • 9. The Schedule for the Evaluation of the Individual Quality of Life-Direct Weighting (SEIQoL-DW) (quality of life)
  • 10. Placebo Questionnaire
  • Patients will be selected according to strict inclusion criteria, including but not limited to their level of impairment, physiology of the stroke lesion, psychological and cognitive characteristics.
  • All participants should fulfill the following criteria:
  • 1. Paralysis of one hand with no residual active finger extension
  • 2. Considerable motor impairment in the upper-limb, with MRC (Medical Research Council) below 2 out of 5 (5 = muscle contraction against full resistance, normal; 4 = reduced strength, but contraction can still move joint against resistance; 3 = strength further reduced such that joint can be moved only against gravity with examiner's resistance completely removed; 2 = muscle can only move if resistance of gravity is removed; 1 = only a trace or flicker of movement is seen or felt, or muscle twitching/spasms (fasciculations) are observed; 0 = no movement).
  • 3. Ischemic or hemorrhagic stroke with subcortical damage and, if possible, intact motor cortex.
  • 4. Time since stroke of at least 9 months (chronic stage)
  • 5. Age 18 to 70
  • 6. No psychiatric or neurological condition other than stroke
  • 7. No cerebellar lesion or bilateral motor deficit
  • 8. No pregnancy
  • 9. No claustrophobia
  • 10. No epilepsy or medication for epilepsy during the last 6 months
  • 11. Eligibility to undergo magnetic resonance imaging (MRI)
  • 12. Ability to understand and follow instructions

排除标准

  • 1. Drug and/or alcohol abuse
  • 2. Psychiatric disorder (including post-stroke depression)
  • 3. Cerebellar damage
  • 4. Bilateral motor deficit
  • 5. Uncontrolled health problems (coronary heart disease, severe heart failure in stage III-IV according to NYHA, severe cardiac arrhythmia, severe edema, severe arthritis, malignant tumor, chronic renal failure)
  • 6. Cognitive impairment (Mini Mental State below 23/30 points). Patients with cognitive or language difficulties that will prevent them giving informed consent and/or follow instructions
  • 7. Pregnancy
  • 8. Drug-resistant epilepsy
  • 9. Pacemakers, metallic implants (ferromagnetic) or claustrophobia, contraindications to undergo magnetic resonance imaging (MRI)

研究者

发起方
Instituto de Investigación Sanitaria Biodonostia (Spain)

相似试验